COMMUNIQUÉS West-GlobeNewswire

The Race to Speed Up the Effects of Cannabis -- CFN Media
03/10/2018
SEATTLE, Oct. 03, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Phoenix Life Sciences International Announces New Board of Directors and Executive Team
03/10/2018
DENVER, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (OTC: MJMD) (“Phoenix Life”), an adaptive healthcare solutions company, today announced its new Board of Directors and executive team [...]
CENTOGENE and Denali Therapeutics Announce Strategic Collaboration to Recruit LRRK2 Patients for Clinical Trials
03/10/2018
CENTOGENE to conduct a targeted global identification and recruitment campaign to support Denali´s LRRK2 inhibitor program ROSTOCK, Germany and SOUTH SAN FRANCISCO, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- CENTOGENE [...]
Technology Innovators, Experienced Systems Integrators Join Cerner in Mission to Modernize Veterans' Electronic Health Records
03/10/2018
KANSAS CITY, Mo. , Oct. 03, 2018 (GLOBE NEWSWIRE) -- Today, Cerner announced it has established a team of industry leaders and innovators with extensive experience in large enterprise systems and commercial sectors to [...]
MannKind Presents New Scientific Data at 54th Annual Meeting of the European Association for the Study of Diabetes
03/10/2018
Presentation 55 Total and severe hypoglycemia is reduced with use of inhaled Technosphere® Insulin (TI) relative to insulin aspart in type 1 diabetes Poster 1046; PS 097 Diabetes duration, BMI, and HbA1c have greater [...]
Cue Biopharma Appoints Hon. Randall R. Rader to Chair Company’s Intellectual Property Committee
03/10/2018
CAMBRIDGE, Mass., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Cue Biopharma , Inc., (NASDAQ: CUE) an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human [...]
CymaBay Therapeutics Announces Additional Positive Results from its Ongoing Phase 2 Study of Seladelpar in Patients with PBC will be Presented During the Late-Breaking Session at The Liver Meeting®
03/10/2018
52-week analysis highlights the potential for seladelpar to offer patients improved efficacy and better tolerability than existing second line treatment Third consecutive year data from the development of seladelpar in [...]
JSC Olainfarm holds Second Quarter 2018 Investor Conference Webinar
03/10/2018
Olainfarm holds Second Quarter 2018 Investor Conference Webinar JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on [...]
Scythian Biosciences Appoints Brady Cobb as CEO
03/10/2018
Company Also Names Andy DeFrancesco Chief Investment Officer TORONTO, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (CSE:SCYB) (Frankfurt:9SB) (OTC – Nasdaq Intl:SCCYF) [...]
Zosano Pharma Engages Contract Manufacturer as Part of the Commercialization Strategy for M207
03/10/2018
FREMONT, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company developing and commercializing therapies that deliver [...]
VistaGen Therapeutics Receives FDA Fast Track Designation for Development of AV-101 as a Non-Opioid Treatment for Neuropathic Pain
03/10/2018
Designation highlights serious unmet need for new treatment options for patients suffering from neuropathic pain Second FDA Fast Track designation for AV-101 since December 2017 marks another milestone for VistaGen's R [...]
Aleafia Announces Options Grant
03/10/2018
TORONTO, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. ( TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH ) (“ Aleafia “) or (the “ Company “), one of Canada’s leading, vertically integrated cannabis companies, is announcing [...]
Nexstim Plc Launches Presence in Asia with Distribution Agreement of its SmartFocus(TM) TMS system to Access Hong Kong Market
03/10/2018
Nexstim Plc Launches Presence in Asia with Distribution Agreement of its SmartFocus(TM) TMS system to Access Hong Kong Market First NBT ® system for applications in depression already installed in Hong Kong Press [...]
Achaogen Highlights Multiple Plazomicin Presentations at IDWeek 2018
03/10/2018
SOUTH SAN FRANCISCO, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing, and commercializing innovative antibacterial agents to address multi- [...]
Sanford Health Announces Adoption of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment
03/10/2018
Medical facility becomes first in South Dakota to offer intraoperative radiation therapy with the revolutionary Xoft System to improve patient care NASHUA, N.H. and SIOUX FALLS, S.D., Oct. 03, 2018 (GLOBE NEWSWIRE) -- [...]
Forty Seven Inc. Appoints Leading Experts in Immuno-Oncology to its Scientific Advisory Board (SAB)
03/10/2018
MENLO PARK, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV) today announced the formation of its Scientific Advisory Board (SAB), comprised of four leading scientists in the fields of [...]
Robert Foster Appointed Acting Chief Executive Officer of ContraVir Pharmaceuticals, Inc.
03/10/2018
EDISON, N.J., Oct. 03, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]
Entasis Therapeutics to Present on ETX2514SUL at IDWeek 2018
03/10/2018
WALTHAM, Mass., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Entasis Therapeutics (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced [...]
CTD announces encouraging top-line data from two ongoing clinical trials of Trappsol® Cyclo™ administered intravenously in Niemann Pick Disease Type C (NPC)
03/10/2018
ALACHUA, Fla., Oct. 03, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease, today announced initial [...]

Pages